Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
Katie is recorded as Analyst at H.C. Wainwright. Katie has spoken on 11 earnings calls across 8 companies, most recently for Angiodynamics Inc on October 8, 2026. Those appearances were for Angiodynamics Inc (ANGO), Vivos Therapeutics, Inc. (VVOS), Volitionrx Ltd (VNRX), Rockwell Medical, Inc. (RMTI), NeuroPace Inc (NPCE) and 3 other companies. The companies whose calls Katie spoke on are classified in the Healthcare sector.
“Looking at relief, what does that program need to demonstrate for you to commit to a larger BPH program? Symptom improvement, durability, what are you guys looking for?”
“The release, and you guys have described the cardiology partnerships in Florida and Arizona as approaching finalization. What kind of capital does each one require?”
“Thinking about your revenue quarter over quarter, how much of the first half's growth was one-time deferred revenue versus catch-up versus organic growth and ramp.”
“Beyond the manufacturing costs and volume drivers you've called out, is there a product mix component to the West Coast growth and to your path towards the high end of the 18 to 22 percent margin guide?”
“This may be something you're not quite ready to answer yet, but looking at your new AI assistant, is it priced or monetized separately from the RNS system or bundled into existing pricing?”
H.C. Wainwright
Analyst
Transcript header (unverified)
ANGO
Medical Instruments & Supplies · Healthcare
VNRX
Medical Devices · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
NPCE
Medical Devices · Healthcare
RGNX
Biotechnology · Healthcare
BWAY
Medical Devices · Healthcare
